347 related articles for article (PubMed ID: 19597113)
1. Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation.
Renner AB; Fiebig BS; Cropp E; Weber BH; Kellner U
Arch Ophthalmol; 2009 Jul; 127(7):907-12. PubMed ID: 19597113
[TBL] [Abstract][Full Text] [Related]
2. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
[TBL] [Abstract][Full Text] [Related]
3. Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.
Murro V; Mucciolo DP; Passerini I; Palchetti S; Sodi A; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2099-2111. PubMed ID: 28752371
[TBL] [Abstract][Full Text] [Related]
4. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
[TBL] [Abstract][Full Text] [Related]
5. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.
Mura M; Sereda C; Jablonski MM; MacDonald IM; Iannaccone A
Arch Ophthalmol; 2007 Aug; 125(8):1107-13. PubMed ID: 17698759
[TBL] [Abstract][Full Text] [Related]
6. Choroideremia carriers maintain a normal electro-oculogram (EOG).
Yau RJ; Sereda CA; McTaggart KE; Sauvé Y; MacDonald IM
Doc Ophthalmol; 2007 May; 114(3):147-51. PubMed ID: 17333094
[TBL] [Abstract][Full Text] [Related]
7. THE NATURAL HISTORY OF FULL-FIELD STIMULUS THRESHOLD DECLINE IN CHOROIDEREMIA.
Dimopoulos IS; Freund PR; Knowles JA; MacDonald IM
Retina; 2018 Sep; 38(9):1731-1742. PubMed ID: 28800019
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.
Huang AS; Kim LA; Fawzi AA
Arch Ophthalmol; 2012 Sep; 130(9):1184-9. PubMed ID: 22965595
[TBL] [Abstract][Full Text] [Related]
9. Clinical findings in a carrier of a new mutation in the choroideremia gene.
Potter MJ; Wong E; Szabo SM; McTaggart KE
Ophthalmology; 2004 Oct; 111(10):1905-9. PubMed ID: 15465555
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.
Jauregui R; Park KS; Tanaka AJ; Cho A; Paavo M; Zernant J; Francis JH; Allikmets R; Sparrow JR; Tsang SH
Am J Ophthalmol; 2019 Nov; 207():77-86. PubMed ID: 31181178
[TBL] [Abstract][Full Text] [Related]
11. Autofluorescence in female carriers with choroideremia: A familial case with a novel mutation in the
Ortiz-Ramirez GY; Villanueva-Mendoza C; Zenteno Ruiz JC; Reyes M; Cortés-González V
Ophthalmic Genet; 2020 Dec; 41(6):625-628. PubMed ID: 32835561
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings.
Iino Y; Fujimaki T; Fujiki K; Murakami A
Jpn J Ophthalmol; 2008; 52(4):289-297. PubMed ID: 18773267
[TBL] [Abstract][Full Text] [Related]
13. CLINICAL CHARACTERISTICS AND MOLECULAR GENETIC ANALYSIS OF A COHORT OF CHINESE PATIENTS WITH CHOROIDEREMIA.
Han X; Wu S; Li H; Zhu T; Wei X; Zhou Q; Sui R
Retina; 2020 Nov; 40(11):2240-2253. PubMed ID: 31922496
[TBL] [Abstract][Full Text] [Related]
14. Peculiar Clinical Findings in Young Choroideremia Patients: A Retrospective Case Review.
Mucciolo DP; Murro V; Sodi A; Passerini I; Giorgio D; Virgili G; Rizzo S
Ophthalmologica; 2019; 242(4):195-207. PubMed ID: 31416074
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Genetic Features of Choroideremia in Childhood.
Khan KN; Islam F; Moore AT; Michaelides M
Ophthalmology; 2016 Oct; 123(10):2158-65. PubMed ID: 27506488
[TBL] [Abstract][Full Text] [Related]
16. Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
Vajaranant TS; Fishman GA; Szlyk JP; Grant-Jordan P; Lindeman M; Seiple W
Ophthalmology; 2008 Apr; 115(4):723-9. PubMed ID: 18201765
[TBL] [Abstract][Full Text] [Related]
17. High-resolution images of retinal structure in patients with choroideremia.
Syed R; Sundquist SM; Ratnam K; Zayit-Soudry S; Zhang Y; Crawford JB; MacDonald IM; Godara P; Rha J; Carroll J; Roorda A; Stepien KE; Duncan JL
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):950-61. PubMed ID: 23299470
[TBL] [Abstract][Full Text] [Related]
18. Multimodal assessment of choroideremia patients defines pre-treatment characteristics.
Seitz IP; Zhour A; Kohl S; Llavona P; Peter T; Wilhelm B; Zrenner E; Ueffing M; Bartz-Schmidt KU; Fischer MD
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2143-50. PubMed ID: 25744334
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene.
Rudolph G; Preising M; Kalpadakis P; Haritoglou C; Lang GE; Lorenz B
Ophthalmic Genet; 2003 Dec; 24(4):203-14. PubMed ID: 14566650
[TBL] [Abstract][Full Text] [Related]
20. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.
Dimopoulos IS; Hoang SC; Radziwon A; Binczyk NM; Seabra MC; MacLaren RE; Somani R; Tennant MTS; MacDonald IM
Am J Ophthalmol; 2018 Sep; 193():130-142. PubMed ID: 29940166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
